Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Current Taxes (2024 - 2025)

Kura Oncology (KURA) has disclosed Current Taxes for 2 consecutive years, with $239000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Current Taxes fell 88.4% to $239000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $239000.0, a 88.4% decrease, with the full-year FY2025 number at $239000.0, down 88.4% from a year prior.
  • Current Taxes was $239000.0 for Q4 2025 at Kura Oncology, down from $2.3 million in the prior quarter.
  • In the past five years, Current Taxes ranged from a high of $2.3 million in Q1 2025 to a low of $239000.0 in Q4 2025.